Browsing: real estate

The firm is raising its outlook again on tech giant Apple, and expects a strong earnings report on iPhone dominance and a rebound in demand in…

Analysts and investors took to CNBC to discuss the latest action for Amazon shares. …

"Ask Halftime" traders answer your questions about individual stocks and ETFs. …

Investors have been treading lightly around ether this year, but with "Shanghai" uncertainty out of the way, ether may finally catch up with bitcoin. …

Follow Cerity Partners Chief Equity Strategist Jim Lebenthal as he previews big bank earnings and how he is positioning his money for what's to come. …

Bank of America screened for underowned stocks its analysts think could top Wall Street's first-quarter earnings estimates. …

Goldman Sachs is eyeing call options on two of the biggest players in the tech industry, as earnings week could bring a major lift to both…

Weight-loss drug Wegovy has had a successful relaunch, while diabetes drug Ozempic has seen accelerating growth, Credit Suisse said. …

Evercore ISI's analyst listed two of his favorite names in the sector, and one stock to bet against. …

Retail traders appear to be selectively buying the dip in some stocks hit hard by the regional bank crisis, according to JPMorgan. …

Here are the biggest calls on Wall Street on …

Citi thinks it's time to buy Steven Madden shares. …

Citi upgraded Merck shares to buy and raised its price target to $130. The firm believes that Merck's drug pipeline is underappreciated by the market.  …

Analyst Corinne Blanchard downgraded the stock to hold from buy. Blanchard noted that it's is expensive after rallying 39% this year and 42% since November. …